DPP4 and metabolic dysfunction-associated steatotic liver disease: As shown in Figure 9H, gardenoside acted as a DPP4 inhibitor to reduce the activity of DPP4 in mice of the NAFLD model, and a similar observation was also made in the si-CTCF treatment group.